Hextend 6 g/100mL
HETASTARCH · INJECTION, SOLUTION · Hospira, Inc.
No Recall History
Plain English
Hextend is a injection, solution containing hetastarch at 6 g/100mL, taken intravenous. Manufactured by Hospira, Inc..
Key Facts
- Brand Name
- Hextend
- Generic Name
- HETASTARCH
- NDC Code (Product)
0409-1555- Manufacturer
- Hospira, Inc.
- Strength
- 6 g/100mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BN200952
- Drug Class
- Plasma Volume Expander [EPC]
- Marketing Start
- 02/02/2005
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
exposure during pregnancy42 reports
bradycardia33 reports
hypotension33 reports
live birth32 reports
drug interaction9 reports
rash9 reports
stevens-johnson syndrome9 reports
drug ineffective8 reports
off label use8 reports
toxic epidermal necrolysis8 reports
Frequently Asked Questions
What is Hextend used for?
Hextend contains HETASTARCH. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is Hextend a controlled substance?
Hextend is not classified as a controlled substance by the DEA.
What is the generic name for Hextend?
The generic name for Hextend is HETASTARCH. There are 1 other brand versions of HETASTARCH.
What is the NDC code for Hextend 6 g/100mL?
The NDC (National Drug Code) for Hextend 6 g/100mL is 0409-1555, listed by Hospira, Inc..